Clinical Trial Update: A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung [Phase 2]

View source ↗

Summary

This document reports the completion status of a Phase II trial evaluating the TX regimen as first-line treatment for Asian elderly patients with advanced adeno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED